#stankostrong…” On April 29, 2024, Jonathan Stanko received a diagnosis of stage four Adenocarcinoma gastric cancer. On May 10, 2024, he shared his journey in a blog post. Jonathan Stanko ...

There is conflicting data regarding the clinicopathological significance of the risk factors associated with Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC). To address this ...

Clear cell carcinoma (CCC) is a rare and aggressive form of cancer that can arise from endometriosis, particularly in the abdominal wall. Endometriosis is a condition where tissue similar to the ...

The Gastric Cancer Registry: A multi-omic cellular and molecular resource for cancer biomarker and therapeutic discovery. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

Concordance between PD-L1 assays 28-8 and SP263 and their respective scoring algorithms in procured upper gastrointestinal adenocarcinoma samples. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in ...

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

Recognising the pressing need for new therapies, the FDA has already granted a fast-track designation to zolbetuximab for the treatment of gastric and GEJ adenocarcinoma. Other companies ...

The Nagaland Institute of Medical Sciences and Research (NIMSR), Kohima, observed World Cancer Day on February 4, with the ...